Dann, Eldad J <br/><br/>
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma.  [electronic resource] 

 -  Human reproduction (Oxford, England)  Aug 2005 
 - 2247-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0268-1161 
<br/><br/><label>Standard No.: </label>10.1093/humrep/dei018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Fertility<br/>Follow-Up Studies<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Ovary--drug effects<br/>Prednisone--administration & dosage<br/>Pregnancy<br/>Pregnancy Outcome<br/>Primary Ovarian Insufficiency--chemically induced<br/>Vincristine--administration & dosage